chronic atrophic gastritis
Conditions
Interventions
Fu's Subcutaneous Needling Group:Fu's Subcutaneous Needling therapy will be administered. Disposable FSN needles (Model M, Nanjing Paifu Medical Technology Co., Ltd.) will be used. During each session
Active Drug Control Group (Wei Fu Chun Capsule):Oral administration of Wei Fu Chun Capsules (Hangzhou Huqingyutang Group Co., Ltd., 0.35g/capsule). The dosage is 4 capsules, three times daily. The tre
Sponsors
Nanjing Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients meeting the diagnostic criteria for Chronic Atrophic Gastritis (CAG). 2. Helicobacter pylori (H. pylori)-negative status, or a documented history of H. pylori infection with successful eradication therapy completed at least six months prior to enrollment and no evidence of current infection. 3. Age between 18 and 65 years, inclusive. 4. Willingness to participate in the study and provision of written informed consent.
Exclusion criteria
Exclusion criteria: 1. History of prior gastric surgery. 2. Regular use of medications that may influence gastric physiology or the study outcomes, including proton pump inhibitors, H2 receptor antagonists, or gastric mucosal protective agents. 3. Presence of significant comorbid conditions that could confound study assessments, such as severe hematologic, hepatic, cardiac, or renal diseases, or active malignancy. 4. Pregnant or lactating individuals.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gastric Mucosa Histopathology Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Effective Rate of Gastric Mucosa Improvement;Traditional Chinese Medicine Symptom Score;Effective Rate of Traditional Chinese Medicine Syndrome Improvement;Serum Assessment Parameters; | — |
Countries
China
Contacts
Public ContactSHI Juanjuan
Nanjing Hospital of Chinese Medicine
Outcome results
None listed